Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
Yahoo/Benzinga
Thu, 07/25/24 - 11:30 am
AbbVie
earnings
AbbVie axes midstage Alzheimer's program amid 'evolving landscape'
Fierce Biotech
Thu, 07/25/24 - 11:30 am
AbbVie
Alzheimer's disease
ABBV-916
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
BioPharma Dive
Tue, 07/16/24 - 12:06 pm
Sionna Therapeutics
cystic fibrosis
AbbVie
Vertex Pharmaceuticals
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
AbbVie led the way in paying doctors to pitch its drugs last year
Axios
Mon, 07/15/24 - 09:57 am
AbbVie
physician payments
AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis
Managed Healthcare Executive
Sun, 07/14/24 - 10:12 pm
AbbVie
Rinvoq
FDA
EMA
giant cell arteritis
AbbVie’s Humira continues to lose market share as biosimilars gain ground
BioSpace
Fri, 07/12/24 - 11:35 am
AbbVie
Humira
biosimilars
AbbVie asks Supreme Court to uphold attorney-client privilege in AndroGel lawsuit
Fierce Pharma
Thu, 07/11/24 - 11:02 pm
AbbVie
Androgel
legal
Supreme Court
generics
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave
Fierce Biotech
Thu, 06/27/24 - 11:27 am
AbbVie
M&A
Celsius Therapeutics
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
BioSpace
Thu, 06/27/24 - 11:25 am
FDA
AbbVie
Genmab
Epkinly
relapsed or refractory follicular lymphoma
FDA Again Hits AbbVie Parkinson’s Treatment With Complete Response Letter
BioSpace
Tue, 06/25/24 - 11:29 am
AbbVie
Parkinson's Disease
FDA
ABBV-951
FDA approves Abbvie's Skyrizi for ulcerative colitis
PR Newswire
Tue, 06/18/24 - 07:56 pm
AbbVie
FDA
Skyrizi
ulcerative colitis
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters
Thu, 06/13/24 - 11:07 am
AbbVie
FutureGen
China
IBD
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters
Fri, 06/7/24 - 11:32 am
AbbVie
Humira
biosimilars
After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype
Fierce Pharma
Thu, 06/6/24 - 09:13 pm
AbbVie
antibody-drug conjugates
Elahere
Immunogen
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena
Thu, 06/6/24 - 11:31 am
AbbVie
clinical trials
ABBV-383
Multiple Myeloma
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »